-
Recent Posts
- Lack of trust in hospitals a major deterrent for blood donation among African-Americans
- The cost of over-triage on our nation’s health system
- IV drips can be left in place
- World’s first transcontinental anesthesia
- Mount Sinai researchers analyze impact of chemical BPA in dental sealants used in children
- A smart use for wisdom teeth: Making stem cells
- Research shows unemployment programs lacking for people with disabilities
- Drug holds promise to halt debilitating condition of diabetes
- Special focus on glycomics in OMICS: A Journal of Integrative Biology
- Sizing up stockpiles of children’s vaccines
Tag Archives: breast cancer symposium
Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy
SAN ANTONIO — Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a … Continue reading
Posted in Health & Medicine
Tagged adjuvant chemotherapy, amp research, breast cancer researcher, breast cancer symposium, cancer recurrence, cancer research, cancer therapy, cancer treatment, concurrent treatment, ctrc, dr perez, global implications, her2 breast cancer, Herceptin, san antonio breast, san antonio breast cancer, san antonio breast cancer symposium, world each year
Leave a comment
Novel drug combo improves breast cancer survival
SAN ANTONIO (AP) — Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other medicines, … Continue reading
Posted in Health & Medicine
Tagged advanced breast cancer, avastin, blood clots in the lungs, brain, breast cancer patients, breast cancer specialist, breast cancer symposium, breast cancers, college of medicine, colon cancer, duke university, food and drug administration, GlaxoSmithKline, kidney problems, m d anderson cancer center, san antonio breast, san antonio breast cancer, san antonio breast cancer symposium, sick women, survival advantage, survival benefit, target tumors, university of texas m d anderson cancer center
Leave a comment
